PAM
PTGX icon

Panagora Asset Management’s Protagonist Therapeutics PTGX Stock Holding History

Panagora Asset Management’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$715K Sell
5,832
-110,777
-95% -$11.6M ﹤0.01% 809
2026
Q1 		$12.3M Sell
116,609
-8,775
-7% -$777K 0.05% 299
2025
Q4 		$11M Sell
125,384
-23,345
-16% -$1.91M 0.04% 284
2025
Q3 		$9.88M Sell
148,729
-61
-0% -$3.47K 0.04% 279
2025
Q2 		$8.22M Sell
148,790
-1,118
-0.7% -$53.7K 0.04% 282
2025
Q1 		$7.25M Buy
+149,908
New +$6.28M 0.04% 294
2022
Q1 		– Sell
-7,225
Closed -$247K – 1577
2021
Q4 		$247K Sell
7,225
-24,212
-77% -$765K ﹤0.01% 1425
2021
Q3 		$557K Sell
31,437
-105,761
-77% -$4.51M ﹤0.01% 1271
2021
Q2 		$6.16M Sell
137,198
-92,315
-40% -$3.05M 0.03% 394
2021
Q1 		$5.94M Sell
229,513
-7,169
-3% -$181K 0.03% 423
2020
Q4 		$4.77M Buy
236,682
+77,828
+49% +$1.68M 0.03% 443
2020
Q3 		$3.11M Buy
158,854
+8,160
+5% +$153K 0.02% 506
2020
Q2 		$2.66M Buy
150,694
+105,195
+231% +$1.32M 0.02% 572
2020
Q1 		$321K Buy
+45,499
New +$341K ﹤0.01% 1296
2018
Q4 		– Sell
-3,107
Closed -$32K – 2508
2018
Q3 		$32K Sell
3,107
-2,666
-46% -$22.9K ﹤0.01% 2127
2018
Q2 		$39K Hold
5,773
– – ﹤0.01% 2087
2018
Q1 		$50K Buy
+5,773
New +$109K ﹤0.01% 2033

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Panagora Asset Management's PTGX Position: Q2 2026 in Review

Panagora Asset Management reduced its Protagonist Therapeutics (PTGX) stake by 95% in Q2 2026, selling an estimated $11.6M and leaving 5,832 shares worth $715K. The position accounts for ﹤0.01% of the portfolio, ranked #809.

Panagora Asset Management first reported a position in PTGX in Q1 2018 and has held it in 17 quarters since. The position peaked at $12.3M in Q1 2026. 343 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

  • Panagora Asset Management held 5,832 shares of Protagonist Therapeutics worth $715K as of Q2 2026.
  • Panagora Asset Management sold 110,777 Protagonist Therapeutics shares in Q2 2026, an estimated $11.6M.
  • Protagonist Therapeutics made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #809 holding.
  • Panagora Asset Management first reported a position in Protagonist Therapeutics in Q1 2018 and has held it in 17 quarters since.
  • Panagora Asset Management's Protagonist Therapeutics position peaked at $12.3M in Q1 2026.
  • 343 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.